Abstract CT013: Phase I trial evaluating BNT116, a TAA-encoding mRNA vaccine, in combination with cemiplimab in frail patients with advanced non-small cell lung cancer (NSCLC)

Authors: Rafal Dziadziuszko, Dániel Deme, Rodryg Ramlau, Erdem Göker, Bulent Yalcin, Neru Munshi, Janet L. Markman, Victoria Chen, Manas Kumar Rout, Chiara Dalle Fratte, Tobias Burkard, Iryna Tsyhankova, Chris D. Hermann, Michael Wenger, Israel Lowy, Frank Seebach, Patrick Forde, Akin Atmaca, Özlem Türeci, Uğur Şahin, Patrick Brueck

Published: 2025-04-25

DOI: 10.1158/1538-7445.am2025-ct013

Source: Full article